United States

Allison Martell

Companies file suit in Canada challenging new rules to lower drug prices

Aug 23 2019

Five pharmaceutical companies said on Friday they have filed a complaint in a Canadian court challenging the constitutionality of new Canadian regulations meant to lower patented drug prices, setting up a fight with the federal government ahead of an Oct. 21 election.

Canadian drug price regulator may be flexible on rare diseases

Aug 13 2019

TORONTO Canada's patented drug price regulator, set to gain new powers next year, may be "more forgiving" in setting price caps for drugs that treat rare diseases, the agency's executive director told Reuters, as some advocates warned the country's pricing reforms would hurt patients.

Canada enacts drug price crackdown, in blow to pharmaceutical industry

Aug 09 2019

TORONTO The Canadian government announced final regulations on Friday that should cut billions of dollars from patented drug prices that are among the highest in the world, overcoming heavy opposition from pharmaceutical companies who may eventually challenge the new rules in court.

Drug industry urges Canada to act early on U.S. import plan

Aug 05 2019

TORONTO Canada's main pharmaceutical lobby group has urged the government not to wait for drug shortages before responding to U.S. plans to import Canadian drugs, according to documents seen by Reuters.

Exclusive: Two powerful Canadian provinces argued against federal drug price crackdown

Jul 30 2019

TORONTO/MONTREAL Canada's two most populous provinces, Ontario and Quebec, have privately expressed concerns with a federal government plan to slash the price of patented drugs, arguing that such regulatory changes could hurt investment in life sciences.

Exclusive: Canada warns U.S. against drug import plans, citing shortage concerns

Jul 18 2019

TORONTO Canada opposes any U.S. plans to buy Canadian prescription drugs that might threaten the country's drug supply or raise costs for its own citizens, officials have told U.S. authorities, in a new setback to the Trump administration's efforts to tackle high drug prices, according to documents obtained by Reuters.

Canadian panel calls for universal public drug coverage

Jun 12 2019

OTTAWA/TORONTO A Canadian advisory council studying prescription drug coverage said on Wednesday the federal government should create a C$15.3 billion ($11.5 billion) universal, single-payer public pharmacare system, and warned that the current system requires a major overhaul.

Exclusive: Canada told drugmakers it would limit scope of some new price rules

May 29 2019

TORONTO The Canadian government has assured the pharmaceutical industry that new features of its plan to cut drug costs would apply only to new medicines, Health Canada said, offering some relief to drugmakers even as other regulations could still lower prices of medicines already on the market.

World News